DLB — Dolby Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- $7.66bn
- $6.88bn
- $1.30bn
- 96
- 27
- 78
- 74
2019 September 27th | 2020 September 25th | 2021 September 24th | 2022 September 30th | 2023 September 29th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 256 | 232 | 318 | 184 | 202 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 122 | 108 | 95.8 | 132 | 143 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -94.4 | -81.1 | -24.6 | -56.3 | -42 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 328 | 344 | 448 | 319 | 367 |
Capital Expenditures | -114 | -69 | -54.5 | -59.5 | -30.3 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 57.3 | 203 | 9.55 | -236 | 84.5 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -56.2 | 134 | -44.9 | -296 | 54.2 |
Financing Cash Flow Items | -1.76 | -5.04 | -7.36 | -1.44 | -0.766 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -385 | -208 | -253 | -611 | -237 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -120 | 274 | 153 | -605 | 190 |